PRINCETON, N.J., Aug. 18 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the Election of Joel A. Tune as a new member of its Board of Directors.
Along with providing expert guidance and strategic direction focused on Laureate's contract manufacturing business, Mr. Tune brings to Laureate more than 20 years of experience in P&L, strategy, operations, marketing and engineering leadership, in rapid-growth and transitional health products and service businesses. Throughout his career, he has worked in general management, sales and marketing, strategy, business development and engineering.
"Joel's exceptional mix of contract manufacturing expertise, in-depth knowledge of customer needs, and strong leadership skills will enable us to propel Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services," said Robert J. Broeze, Ph.D., President & Chief Executive Officer of Laureate." As we continue to enhance the value proposition for our customers and to continue to build upon our momentum, we look to our new partnership with Joel to help aid in achieving our objectives for 2009 and beyond."
Mr. Tune most recently served as Vice President / General Manager, Global Drug Delivery of Baxter International where he transformed an established business, doubling revenues over five years to reach $800M+. Mr. Tune realigned the business model, products and market focus toward high value, rapidly expanding outsourcing services and technologies. He also successfully led a 14-member leadership team; 200 busines
|SOURCE Laureate Pharma, Inc.|
Copyright©2009 PR Newswire.
All rights reserved